A drug for advanced ovarian cancer has been approved for use in newly diagnosed patients in England, after a trial showed it could delay progression of the disease for three years. Up to 600 women with a hereditary type of the disease could benefit each year. Health bosses said olaparib had the potential to make… Read More: Ovarian cancer drug olaparib ‘can delay disease in newly diagnosed’ »
Industry watchers have been speculating for months about just how high Novartis would price gene therapy Zolgensma on approval—and just how payers would cover it. And with the FDA’s green light, they now have an answer. The Swiss drugmaker will roll out the drug, a one-time treatment for pediatric patients less than 2 years of… Read More: Novartis slaps $2M-plus price tag on newly approved gene therapy… »
Of the 16 million American adults who live with depression, as many as one-quarter gain little or no benefit from available treatments, whether drugs or talk therapy. They represent perhaps the greatest unmet need in psychiatry. On Tuesday, the Food and Drug Administration approved a prescription treatment intended to help them, a fast-acting drug derived… Read More: Fast-Acting Depression Drug, Newly Approved, Could Help Millions »
Cleveland Clinic has now officially rebranded four hospitals whose acquisition deals recently closed. Indian River Medical Center and Martin Health System leaders met with Cleveland Clinic officials Thursday and they also gathered with caregivers to share their vision for the newly integrated hospitals. THE IMPACT Both acquisitions will broaden Cleveland Clinic’s Florida footprint, as Martin… Read More: Cleveland Clinic rebrands newly acquired Florida hospitals, broadens footprint in… »